Comparison of Nicotine Pharmacokinetics in Healthy Japanese Male Smokers Following Application of the Transdermal Nicotine Patch and Cigarette Smoking(Biopharmacy)
スポンサーリンク
概要
- 論文の詳細を見る
Transdermal nicotine patch (TNP) contains approximately 16.6 and 24.9mg of nicotine per 20 and 30cm^2 (TNP-20 and TNP-30). The aims of the study are to investigate linearity of nicotine pharmacokinetics after single application of different strengths of TNP and to directly compare plasma nicotine concentrations with those during cigarette smoking. Twelve healthy Japanese male smokers were randomly allocated to 1 of 2 cohorts consisting of 6 subjects each. Cohort 1 subjects received 1 sheet of TNP-20 (TNP-20×1) in period 1, and 2 sheets of TNP-20 (TNP-20×2) in period 3. Cohort 2 subjects were received 1 sheet of TNP-30 (TNP-30×1) in period 2, and smoked a total of 12 cigarettes at 1 h intervals in period 4. Each TNP was applied to the upper arm for 16 h. After TNP-20×1 or TNP-20×2 treatment in cohort 1, the amount of nicotine delivered from TNP (Dose) was proportional to surface area of TNP. C_<max> and AUC of nicotine increased with the surface area (Dose), and t_<max>, t_<1/2>, CL/F and percentage of dose excreted in urine were almost the same between both treatments. These suggest the linear pharmacokinetics of nicotine in proportion to the surface area and Dose following single application of TNP in identical subjects. In cohort 2, the plasma nicotine concentrations after TNP-30×1 treatment were approximately half those just before each smoking.
- 公益社団法人日本薬学会の論文
- 2006-05-01
著者
-
Irie Shin
Kyushu Clinical Pharmacology Research Clinic
-
Irie Shin
Kyushu Clinical Pharmacology Research Clinic Medical Co. Lta
-
KIKKAWA Hironori
Departinent of Radiobiochemistry School of Pharmaceutical Sciences, University of Shizuoka
-
SEKIGUCHI Kaneo
Department of Biochemisry, Nagoya Univesity School of Medicine
-
Sobue Satoshi
Department Of Clinical Pharmacology Pfizer Global R&d Tokyo Laboratories Pfizer Japan Inc.
-
Sobue Satoshi
Department Of Clinical Pharmacology Pfizer Global R & D Tokyo Laboratories Pfizer Japan Inc.
-
Kikkawa Hironori
Department Of Clinical Pharmacology Pfizer Global R&d Tokyo Laboratories Pfizer Japan Inc.
-
Kikkawa Hironori
Departinent Of Radiobiochemistry School Of Pharmaceutical Sciences University Of Shizuoka
-
AKASAKI Moriaki
Consumer Healthcare Division, Pfizer Japan Inc.
-
Sekiguchi Kaneo
Department Of Clinical Pharmacology Pfizer Global R&d Tokyo Laboratories Pfizer Japan Inc.
-
Akasaki Moriaki
Consumer Healthcare Division Pfizer Japan Inc.
関連論文
- Prognostic indicators estimated by ^Tc-GSA in acute liver damage
- Role of Sialylglycoconjugate(s) in the Initial Phase of Metastasis of Liver-metastatic RAW117 Lymphoma Cells
- Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection
- Restricted Expression of Xenopus Midkine Gene during Early Development
- Difference in Percutaneous Absorption and Intracutaneous Distribution in Guinea Pigs among Topical Antifungal Drugs : Tioconazole Solution, Tioconazole Cream, Miconazole Nitrate Solution and Bifonazole Solution(Biopharmacy)
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
- Population Pharmacokinetics and Proton Pump Inhibitory Effects of Intravenous Lansoprazole in Healthy Japanese Males(Analytical Biochemistry)
- Effect of Water Intake on Pharmacokinetics of Lansoprazole from Fast Disintegrating Tablet in Human Subjects
- Postural Change-associated Alterations in QT/QTc Intervals on Electrocardiograms
- Comparison of Nicotine Pharmacokinetics in Healthy Japanese Male Smokers Following Application of the Transdermal Nicotine Patch and Cigarette Smoking(Biopharmacy)
- A Novel Single Nucleotide Polymorphism (SNP) of the CYP2C19 Gene in a Japanese Subject with Lowered Capacity of Mephobarbital 4'-Hydroxylation
- Skin Tests of a Novel Nicotine Patch, PHK-301p, in Healthy Male Volunteers : Phase I, Placebo-Controlled Study
- Evaluation of Fast Disintegrating Lansoprazole Tablet in Human Subjects
- Relationship between Genetic Polymorphisms and mRNA Expression of Dihydrofolate Reductase Enzyme in a Healthy Japanese Population